LANNETT CO INC
10KSB, EX-27, 2000-09-28
PHARMACEUTICAL PREPARATIONS
Previous: LANNETT CO INC, 10KSB, EX-11, 2000-09-28
Next: SIENA HOLDINGS INC, 10-K, 2000-09-28



<TABLE> <S> <C>

<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          JUN-30-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                               0
<SECURITIES>                                         0
<RECEIVABLES>                                1,047,518
<ALLOWANCES>                                    63,000
<INVENTORY>                                  2,950,176
<CURRENT-ASSETS>                             4,539,792
<PP&E>                                       7,652,539
<DEPRECIATION>                               2,698,355
<TOTAL-ASSETS>                              12,813,967
<CURRENT-LIABILITIES>                        2,992,719
<BONDS>                                      9,522,846
                                0
                                          0
<COMMON>                                        13,206
<OTHER-SE>                                   2,312,575
<TOTAL-LIABILITY-AND-EQUITY>                12,813,967
<SALES>                                     11,553,457
<TOTAL-REVENUES>                            11,553,457
<CGS>                                        7,890,972
<TOTAL-COSTS>                                9,978,432
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             823,310
<INCOME-PRETAX>                                884,767
<INCOME-TAX>                                 (465,330)
<INCOME-CONTINUING>                          1,350,097
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 1,350,097
<EPS-BASIC>                                       0.15
<EPS-DILUTED>                                     0.15


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission